Polymorphisms at position -308 in the promoter region of the TNF-α and in the first intron of the TNF-β genes and spontaneous and lipopolysaccharide-induced TNF-α release in sarcoidosis

Cytokine

Volumn 11, Issue 11, 1999, Pages 882-887

  Somoskövi, Akos ^a   Zissel, Gernot ^a   Seitzer, Ulrike ^a   Gerdes, Johannes ^a   Schlaak, Max ^a   Müller Quernheim, Joachim ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Gene polymorphisms; Sarcoidosis; TNF release

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL COUNT; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; INTRON; LUNG LAVAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; SARCOIDOSIS; STATISTICAL ANALYSIS;

EID: 0345440097     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0498     Document Type: Article

References (33)

1. Zissel G, Müller-Quernheim J. Sarcoidosis: historical perspective and immunopathogenesis (Part I). Resp Med. 92:1998;126-140.
2. Müller-Quernheim J, Pfeifer S, Männel D, Strausz J, Ferlinz R. Lung restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis. 145:1992;187-192.
3. Bachwich PR, Lynch JP, Larrick J, Spengler M, Kunkel S. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol. 125:1986;421-425.
4. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med. 115:1990;36-42.
5. Kindler V, Sappino A-P, Grau GE, Piguet P-F, Vassali P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 56:1989;731-740.
6. Ziegenhagen M, Benner U, Zissel G, Zabel P, Schlaak M, Müller-Quernheim J. Sarcoidosis: TNFα release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Crit Care Med. 156:1997;1586-1592.
7. Wilson A, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNFα gene detectable by Nco I restriction of PCR product. Hum Mol Gen. 1:1992;353.
8. Messer G, Spengler U, Jung MC, Honold G, Blömer K, Pape GR, Riethmüller G, Weiss EH. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and reduced level of TNF-β production. J Exp Med. 173:1991;209-219.
9. Pociot F, Briant L, Jongeneel CV, Mölvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A. Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 23:1993;224-231.
10. Bouma G, Crusius JBA, Oudkerk Pool M, Kolkman JJ, von Blomberg BME, Kostense PJ, Giphart MJ, Schreuder GMTH, Meuwissen SGM, Peña AS. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphism in the TNF genes and HLA-DR alleles. Relevance for Inflammatory Bowel Disease. Scand J Immunol. 43:1996;456-463.
11. Pociot F, Mölvig J, Wogensen L, Worsaae H, Dalböge H, Baek L, Nerup J. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol. 33:1991;37-49.
12. Stüber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm. 46:1996;42-50.
13. Stüber F, Petersen M, Bokelmann F, Schade FU. A genomic polymorphism within the TNF locus influences TNF-alpha plasma levels and outcome of patients with severe sepsis. Crit Care Med. 24:1996;381-384.
14. Kroeger K, Carville K, Abraham L. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol. 34:1997;391-399.
15. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter transcriptional activation. Procl Natl Acad Sci U S A. 94:1997;3195-3199.
16. Brinkmann BM, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFα gene regulation. J Inflamm. 46:1996;32-41.
17. McGuire W, Hill AVS, Allsop CEM, Greenwood BM, Kwiatkowski D. Variation in the TNFα promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
18. Cabrera M, Shaw M-A, Sharples C, Williams H, Castes M, Convit J, Blackwell JM. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 182:1995;1259-1264.
19. Roy S, McGuire W, Mascie-Taylor CGN, Saha B, Hazra SK, Hill AVS, Kwiatkowski D. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis. 176:1997;530-532.
20. Manus R, Wilson AG, Mansfield J, Weir D, Duff G, Kelleher D. TNF2, a polymorphism of the tumour necrosis-α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol. 26:1996;2113-2118.
21. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte B, Emery PP, Duff GW. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol. 24:1994;191-195.
22. Seitzer U, Swider C, Stüber F, Suchnicki K, Lange A, Richter E, Zabel P, Müller-Quernheim J, Flad HD, Gerdes J. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine. 9:1997;787-790.
23. Müller-Quernheim J. Sarcoidosis: clinical manifestations, staging and therapy (Part II). Resp Med. 92:1998;140-150.
24. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med. 305:1981;429-434.
25. Bøyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol. 17:1983;429-436.
26. Ishihara M, Ohno S, Ishida T, Mizuki N, Ando H, Naruse T, Ishihara H, Inoko H. Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis. Tissue Antigens. 46:1995;59-62.
27. Müller-Quernheim J, Pfeifer S, Strausz J, Ferlinz R. Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am Rev Respir Dis. 144:1991;1322-1329.
28. Müller-Quernheim J, Saltini C, Sondemeyer P, Crystal RG. Compartmentalized activation of the interleukin-2 gene by lung T-lymphocytes in active sarcoidosis. J Immunol. 137:1986;3475-3483.
29. Sariban E, Imamura K, Luebbers R, Kufe D. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest. 81:1988;1506-1510.
30. Cox A, Gonzales AM, Wilson AG, Wilson RM, Ward JD, Artlett CM, Welsh K, Duff GW. Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia. 37:1994;500-503.
31. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Plutte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 177:1993;557-560.
32. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 156:1997;1601-1605.
33. Mullighan Ch, Fannin G, Chapel H, Welsh K. TNF and lymphotoxin-α polymorphisms associated with common variable immunodeficiency: Role in the pathogenesis of granulomatous disease. J Immunol. 159:1997;6236-6241.